4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000899243-19-026127
EVP, Chief Financial Officer sold 13,834 shares at an average $120.45 ($1,666,271)
- EVP, Chief Financial Officer acquired 11,231 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Burke William P. Mr. · EVP, Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-10-25 | Exercise or conversion : show line 1 in the form | +11,231 | $34.21 | $384,213 | 24,245 | D |
| 2019-10-25 | Sale : show line 2 in the form | −6,905 | $119.87 | $827,702 | 17,340 | D |
| 2019-10-25 | Sale : show line 3 in the form | −4,326 | $120.65 | $521,932 | 13,014 | D |
| 2019-10-28 | Sale : show line 4 in the form | −1,155 | $120.33 | $138,981 | 11,859 | D |
| 2019-10-29 | Sale : show line 5 in the form | −1,448 | $122.69 | $177,655 | 10,411 | D |
| Open-market sales · 13,834 sh · avg $120.45 · $1,666,271 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-10-25 | Exercise or conversion : show line 6 in the form Non-qualified Stock Option (Right to Buy) | −11,231 | 11,232 | D |
Loading xslF345X03/doc4.xml…